US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alumis Inc.

4.13

-0.0100-0.24%

Post-market: 4.150.0200+0.48%18:44 EDT

Volume:449.12K

Turnover:1.86M

Market Cap:224.69M

PE:-0.50

High:4.28

Open:4.07

Low:4.00

Close:4.14

Loading ...

Overview Company News Filings

Wall Street Analysts Are Bullish on Top Materials Picks

Wells Fargo Initiates Alumis at Overweight With $17 Price Target

MT Newswires Live

Alumis Inc. : Wells Fargo Initiates Coverage With Overweight Rating and Target Price $17

THOMSON REUTERS

Alumis Inc - Topline Readout Expected in Q3 2026

THOMSON REUTERS

Alumis Inc - Completes Patient Enrollment in Global Lumus Phase 2B Trial of Esk-001

THOMSON REUTERS

Alumis Completes Patient Enrollment in the Global LUMUS Phase 2b Trial of ESK-001, a Next-Generation Oral TYK2 Inhibitor for the Treatment of Systemic Lupus Erythematosus

Alumis promotes Sanam Pangali to chief legal officer

Alumis Inc. Files Initial Beneficial Ownership Statement for Sanam Pangali, Chief Legal Officer

Press Release: Alumis Announces the Promotion of Sanam Pangali to Chief Legal Officer and Corporate Secretary

Alumis files $400M mixed securities shelf

BRIEF-Alumis Files For Mixed Shelf Offering Of Up To $400 Mln

Alumis Price Target Announced at $18.00/Share by Guggenheim

Analysts Are Bullish on These Materials Stocks: Westlake Corporation (WLK), Alumis Inc. (ALMS)

Alumis resumed with an Overweight at Morgan Stanley

Alumis Inc. Files Initial Statement of Beneficial Ownership for Director Lynn A. Tetrault

H.C. Wainwright Remains a Buy on Alumis Inc. (ALMS)

Alumis, Acelyrin Close Merger

MT Newswires Live

Alumis Inc. Completes Merger with ACELYRIN, Inc.

ACELYRIN Completes Merger and Delists from Nasdaq

Alumis Inc. Completes Merger with ACELYRIN, Strengthening Late-Stage Biopharma Portfolio

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ALMS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALMS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALMS\",,,,,undefined,":{"symbol":"ALMS","market":"US","secType":"STK","nameCN":"Alumis Inc.","latestPrice":4.13,"timestamp":1754078400000,"preClose":4.14,"halted":0,"volume":449123,"hourTrading":{"tag":"盘后","latestPrice":4.15,"preClose":4.13,"latestTime":"18:44 EDT","volume":5589,"amount":23164.3964,"timestamp":1754088296610},"delay":0,"floatShares":8663130,"shares":54405544,"eps":-8.309579,"marketStatus":"Closed","change":-0.01,"latestTime":"08-01 16:00:00 EDT","open":4.07,"high":4.28,"low":4,"amount":1859440.9000308,"amplitude":0.067633,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-8.309579,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1754294400000},"marketStatusCode":5,"adr":0,"listingDate":1719547200000,"exchange":"NASDAQ","adjPreClose":4.14,"preHourTrading":{"tag":"盘前","latestPrice":4.1,"preClose":4.14,"latestTime":"08:00 EDT","volume":10656,"amount":45516.581856,"timestamp":1754049602009},"postHourTrading":{"tag":"盘后","latestPrice":4.15,"preClose":4.13,"latestTime":"18:44 EDT","volume":5589,"amount":23164.3964,"timestamp":1754088296610},"volumeRatio":0.472977,"impliedVol":3.2934,"impliedVolPercentile":0.9367},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALMS\",,,,,undefined,":{"symbol":"ALMS","floatShares":8663130,"roa":"-101.07%","roe":"-247.05%","lyrEps":-10.381567,"volumeRatio":0.472977,"shares":54405544,"dividePrice":0,"high":4.28,"amplitude":0.067633,"preClose":4.14,"low":4,"week52Low":2.7601,"pbRate":"1.33","psRate":"12.92","week52High":13.11,"institutionHeld":0,"latestPrice":4.13,"eps":-8.309579,"divideRate":0,"volume":449123,"delay":0,"ttmEps":-8.309579,"open":4.07,"prevYearClose":7.86,"prevWeekClose":3.88,"prevMonthClose":4.14,"prevQuarterClose":3,"fiveDayClose":3.88,"twentyDayClose":3.4,"sixtyDayClose":4.35},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALMS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2554728923","title":"Wall Street Analysts Are Bullish on Top Materials Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2554728923","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554728923?lang=en_us&edition=fundamental","pubTime":"2025-07-28 13:10","pubTimestamp":1753679428,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Materials sector as 2 analysts just weighed in on Alumis Inc. (ALMS – Research Report) and First Quantu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-materials-picks-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-materials-picks-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4544","ALMS","ARKG","BK4007","BK4585","BK4588"],"gpt_icon":0},{"id":"2554388762","title":"Wells Fargo Initiates Alumis at Overweight With $17 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2554388762","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554388762?lang=en_us&edition=fundamental","pubTime":"2025-07-25 19:55","pubTimestamp":1753444544,"startTime":"0","endTime":"0","summary":"Alumis (ALMS) has an average rating of buy and mean price target of $19, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and resea","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALMS"],"gpt_icon":0},{"id":"2554766471","title":"Alumis Inc. : Wells Fargo Initiates Coverage With Overweight Rating and Target Price $17","url":"https://stock-news.laohu8.com/highlight/detail?id=2554766471","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554766471?lang=en_us&edition=fundamental","pubTime":"2025-07-25 18:31","pubTimestamp":1753439487,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250725:nAZN49JCJW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2553842207","title":"Alumis Inc - Topline Readout Expected in Q3 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2553842207","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553842207?lang=en_us&edition=fundamental","pubTime":"2025-07-24 19:35","pubTimestamp":1753356931,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250724:nFWN3TL25V:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2553220782","title":"Alumis Inc - Completes Patient Enrollment in Global Lumus Phase 2B Trial of Esk-001","url":"https://stock-news.laohu8.com/highlight/detail?id=2553220782","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553220782?lang=en_us&edition=fundamental","pubTime":"2025-07-24 19:35","pubTimestamp":1753356931,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250724:nFWN3TL25V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2553880847","title":"Alumis Completes Patient Enrollment in the Global LUMUS Phase 2b Trial of ESK-001, a Next-Generation Oral TYK2 Inhibitor for the Treatment of Systemic Lupus Erythematosus","url":"https://stock-news.laohu8.com/highlight/detail?id=2553880847","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553880847?lang=en_us&edition=fundamental","pubTime":"2025-07-24 19:30","pubTimestamp":1753356600,"startTime":"0","endTime":"0","summary":"-Topline Readout Expected in Q3 2026- SOUTH SAN FRANCISCO, Calif., July  24, 2025  (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted th","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/24/3120949/0/en/Alumis-Completes-Patient-Enrollment-in-the-Global-LUMUS-Phase-2b-Trial-of-ESK-001-a-Next-Generation-Oral-TYK2-Inhibitor-for-the-Treatment-of-Systemic-Lupus-Erythematosus.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4077","BK4007","IFN","ALMS","BK4523","SLE"],"gpt_icon":0},{"id":"2551135712","title":"Alumis promotes Sanam Pangali to chief legal officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2551135712","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551135712?lang=en_us&edition=fundamental","pubTime":"2025-07-15 04:15","pubTimestamp":1752524155,"startTime":"0","endTime":"0","summary":"Alumis (ALMS) announced the promotion of Sanam Pangali to chief legal officer and corporate secretary. Sanam most recently served as senior VP, leg...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alumis-promotes-sanam-pangali-to-chief-legal-officer-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alumis-promotes-sanam-pangali-to-chief-legal-officer-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2551135499","title":"Alumis Inc. Files Initial Beneficial Ownership Statement for Sanam Pangali, Chief Legal Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2551135499","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551135499?lang=en_us&edition=fundamental","pubTime":"2025-07-15 04:15","pubTimestamp":1752524154,"startTime":"0","endTime":"0","summary":"Alumis Inc. has filed an initial statement of beneficial ownership, identifying Sanam Pangali as the beneficial owner. Pangali holds the position of Chief Legal Officer at the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alumis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 14, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250714:nNDL7H2jXy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2551359181","title":"Press Release: Alumis Announces the Promotion of Sanam Pangali to Chief Legal Officer and Corporate Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=2551359181","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551359181?lang=en_us&edition=fundamental","pubTime":"2025-07-15 04:05","pubTimestamp":1752523500,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., July 14, 2025  -- Alumis Inc. , a late-stage biopharma company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced the promotion of Sanam Pangali to Chief Legal Officer and Corporate Secretary. Sanam most recently served as Senior Vice President, Legal of Alumis. In her new role, she will lead all legal and compliance functions, including corporate governance, intellectual property, and strategic advisory on key decisions and transactions. Sanam succeeds Sara Klein, following her retirement from the company.Alumis is a late-stage biopharma company developing next-generation targeted therapies with the potential to significantly improve patient health and outcomes across a range of immune-mediated diseases. Leveraging its proprietary data analytics platform and precision approach, Alumis is developing a pipeline of oral tyrosine kinase 2 inhibitors, consisting of ESK-001 for the treatment of systemic immu","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2548382588","title":"Alumis files $400M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2548382588","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548382588?lang=en_us&edition=fundamental","pubTime":"2025-07-04 02:55","pubTimestamp":1751568909,"startTime":"0","endTime":"0","summary":"14:51 EDT Alumis (ALMS) files $400M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaking fi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alumis-files-400m-mixed-securities-shelf-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alumis-files-400m-mixed-securities-shelf-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2548382847","title":"BRIEF-Alumis Files For Mixed Shelf Offering Of Up To $400 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2548382847","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548382847?lang=en_us&edition=fundamental","pubTime":"2025-07-04 02:52","pubTimestamp":1751568773,"startTime":"0","endTime":"0","summary":"BRIEF-Alumis Files For Mixed Shelf Offering Of Up To $400 MlnJuly 3 (Reuters) - Alumis Inc ALMS.O:ALUMIS INC FILES FOR MIXED SHELF OFFERING OF UP TO $400 MILLION- SEC FILINGSource text: [ID:n0001104659-25-065745]Further company coverage: ALMS.O","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250703:nFWN3T00F1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2542830345","title":"Alumis Price Target Announced at $18.00/Share by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2542830345","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542830345?lang=en_us&edition=fundamental","pubTime":"2025-06-10 23:02","pubTimestamp":1749567720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALMS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 10, 2025 11:02 ET (15:02 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS"],"gpt_icon":0},{"id":"2540729195","title":"Analysts Are Bullish on These Materials Stocks: Westlake Corporation (WLK), Alumis Inc. (ALMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2540729195","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540729195?lang=en_us&edition=fundamental","pubTime":"2025-06-03 16:30","pubTimestamp":1748939420,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Materials sector as 2 analysts just weighed in on Westlake Corporation (WLK – Research Report) and Alum...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-materials-stocks-westlake-corporation-wlk-alumis-inc-alms-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-materials-stocks-westlake-corporation-wlk-alumis-inc-alms-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMS","BK4588","BK4585","BK4544","ARKG","BK4090","BK4007","WLK"],"gpt_icon":0},{"id":"2540324753","title":"Alumis resumed with an Overweight at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2540324753","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540324753?lang=en_us&edition=fundamental","pubTime":"2025-06-02 07:30","pubTimestamp":1748820604,"startTime":"0","endTime":"0","summary":"Morgan Stanley resumed coverage of Alumis (ALMS) with an Overweight rating and $23 price target The firm updated its model for the Acelyrin merger ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alumis-resumed-with-an-overweight-at-morgan-stanley-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alumis-resumed-with-an-overweight-at-morgan-stanley-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMS"],"gpt_icon":0},{"id":"2537154103","title":"Alumis Inc. Files Initial Statement of Beneficial Ownership for Director Lynn A. Tetrault","url":"https://stock-news.laohu8.com/highlight/detail?id=2537154103","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537154103?lang=en_us&edition=fundamental","pubTime":"2025-05-24 04:03","pubTimestamp":1748030639,"startTime":"0","endTime":"0","summary":"Alumis Inc. has filed an initial statement of beneficial ownership. The filing names Lynn A. Tetrault as the beneficial owner, who serves as a Director of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alumis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 23, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nNDL58LCY7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2537138679","title":"H.C. Wainwright Remains a Buy on Alumis Inc. (ALMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2537138679","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537138679?lang=en_us&edition=fundamental","pubTime":"2025-05-23 18:39","pubTimestamp":1747996779,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Mitchell Kapoor reiterated a Buy rating on Alumis Inc. (ALMS – Research Report) today and set a price target of $14.00. The...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-alumis-inc-alms?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-alumis-inc-alms?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2537939084","title":"Alumis, Acelyrin Close Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2537939084","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537939084?lang=en_us&edition=fundamental","pubTime":"2025-05-21 22:14","pubTimestamp":1747836871,"startTime":"0","endTime":"0","summary":"Alumis  said Wednesday that it has completed its merger with Acelyrin .Each Acelyrin shareholder will receive 0.4814 Alumis share for each Acelyrin share owned. Acelyrin shares have ceased trading on Nasdaq.\"This merger allows us to advance our pipeline through multiple planned key data readouts, with a cash runway that now extends into 2027,\" Alumis Chairman, CEO and President Martin Babler, said.Alumis shares were up over 8% in recent trading.Price: 5.28, Change: +0.40, Percent Change: +8.20","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALMS","BK4007","SLRN","BK4139"],"gpt_icon":0},{"id":"2537493914","title":"Alumis Inc. Completes Merger with ACELYRIN, Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2537493914","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537493914?lang=en_us&edition=fundamental","pubTime":"2025-05-21 21:50","pubTimestamp":1747835432,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Alumis Inc. ( ($ALMS) ). On May 21, 2025, Alumis Inc. completed its merger with ACELYRIN, Inc., creating a lead...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alumis-inc-completes-merger-with-acelyrin-inc?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alumis-inc-completes-merger-with-acelyrin-inc?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2537156939","title":"ACELYRIN Completes Merger and Delists from Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2537156939","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537156939?lang=en_us&edition=fundamental","pubTime":"2025-05-21 21:48","pubTimestamp":1747835332,"startTime":"0","endTime":"0","summary":"ACELYRIN, INC. ( ($SLRN) ) has shared an announcement. On May 21, 2025, ACELYRIN, Inc. completed a merger with Alumis, becoming a wholly owned subs...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/acelyrin-completes-merger-and-delists-from-nasdaq?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/acelyrin-completes-merger-and-delists-from-nasdaq?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MNQmain",".IXIC","BK4588","IE00B64PRP62.GBP","BK4112","TQQQ","BK4585","IE00BKPKM429.USD","ALMS","BK4007","NDAQ","IE00B3QW5Z07.USD","USAW.SI","PSQ","LU2210150020.SGD","LU2095319765.USD","SQQQ","NVIW.SI","QID","NQmain","QLD","TSYW.SI","IE00BGHQF748.EUR","LU2210149790.SGD","USJW.SI"],"gpt_icon":0},{"id":"2537359599","title":"Alumis Inc. Completes Merger with ACELYRIN, Strengthening Late-Stage Biopharma Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2537359599","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537359599?lang=en_us&edition=fundamental","pubTime":"2025-05-21 21:16","pubTimestamp":1747833390,"startTime":"0","endTime":"0","summary":"Alumis Inc., a late-stage biopharma company specializing in next-generation targeted therapies for immune-mediated diseases, has successfully completed its merger with ACELYRIN, Inc. This strategic move establishes a leading clinical-stage biopharma company with a robust portfolio and a strong financial position. As part of the merger, ACELYRIN stockholders will receive 0.4814 shares of Alumis common stock for each ACELYRIN share they own. With this merger, Alumis aims to advance its pipeline and extend its cash runway into 2027, ensuring continued development of transformative therapies for patients.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alumis Inc. published the original content used to generate this news brief via EDGAR, th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nNDL1Tk9ws:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALMS","SLRN","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":93,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALMS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-14","symbol":"ALMS","fiscalQuarterEnding":"2025/03","expectedEps":-1.47,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-1.82},{"market":"US","date":"2025-03-19","symbol":"ALMS","fiscalQuarterEnding":"2024/12","expectedEps":-1.39,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742356800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-11-13","symbol":"ALMS","fiscalQuarterEnding":"2024/09","expectedEps":-1.64,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"post","actualEps":-1.73}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALMS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALMS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":8,"updateTime":1753502400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALMS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALMS","date":"2025-07-31","current":-0.649671,"percent":0.843066,"low":-4.913756,"twenty":-3.444923,"median":-1.775039,"eighty":-0.766929,"high":-0.443678,"avg":-2.022824,"sd":1.247992,"marketCap":223062730},"quantilePoints":[{"date":"2024-06-28","current":-4.084559,"twenty":-4.913756,"median":-4.913756,"eighty":-4.416238,"marketCap":689534895},{"date":"2024-07-05","current":-3.516406,"twenty":-4.747917,"median":-3.851156,"eighty":-3.59564,"marketCap":593622147},{"date":"2024-07-12","current":-3.405847,"twenty":-4.063676,"median":-3.825051,"eighty":-3.58397,"marketCap":574958044},{"date":"2024-07-19","current":-4.023985,"twenty":-4.026561,"median":-3.851156,"eighty":-3.52869,"marketCap":679309112},{"date":"2024-07-26","current":-4.023985,"twenty":-4.117224,"median":-3.947896,"eighty":-3.58397,"marketCap":679309112},{"date":"2024-08-02","current":-4.178507,"twenty":-4.123137,"median":-3.980142,"eighty":-3.620209,"marketCap":705394582},{"date":"2024-08-09","current":-3.850149,"twenty":-4.108328,"median":-3.938677,"eighty":-3.693301,"marketCap":649962958},{"date":"2024-08-16","current":-3.683794,"twenty":-4.085032,"median":-3.914533,"eighty":-3.659692,"marketCap":696362265},{"date":"2024-08-23","current":-3.672282,"twenty":-4.078883,"median":-3.855481,"eighty":-3.667968,"marketCap":694186133},{"date":"2024-08-30","current":-3.655014,"twenty":-4.050383,"median":-3.84693,"eighty":-3.659692,"marketCap":690921935},{"date":"2024-09-06","current":-3.442045,"twenty":-4.027205,"median":-3.798947,"eighty":-3.608967,"marketCap":650663491},{"date":"2024-09-13","current":-3.33556,"twenty":-4.023985,"median":-3.741353,"eighty":-3.511116,"marketCap":630534270},{"date":"2024-09-20","current":-3.301025,"twenty":-4.023985,"median":-3.709695,"eighty":-3.405847,"marketCap":624005873},{"date":"2024-09-27","current":-3.211808,"twenty":-3.980142,"median":-3.685233,"eighty":-3.395997,"marketCap":607140850},{"date":"2024-10-04","current":-2.803137,"twenty":-3.959602,"median":-3.672282,"eighty":-3.303903,"marketCap":529888161},{"date":"2024-10-11","current":-2.978693,"twenty":-3.946725,"median":-3.656453,"eighty":-3.263611,"marketCap":563074175},{"date":"2024-10-18","current":-3.462191,"twenty":-3.930629,"median":-3.608967,"eighty":-3.220442,"marketCap":654471723},{"date":"2024-10-25","current":-3.424777,"twenty":-3.915649,"median":-3.608753,"eighty":-3.22332,"marketCap":647399293},{"date":"2024-11-01","current":-3.254977,"twenty":-3.914533,"median":-3.516406,"eighty":-3.231953,"marketCap":615301345},{"date":"2024-11-08","current":-3.459313,"twenty":-3.86344,"median":-3.50536,"eighty":-3.240587,"marketCap":653927690},{"date":"2024-11-15","current":-2.016571,"twenty":-3.859807,"median":-3.465068,"eighty":-3.22332,"marketCap":481504843},{"date":"2024-11-22","current":-2.155567,"twenty":-3.851156,"median":-3.454996,"eighty":-3.18015,"marketCap":514693313},{"date":"2024-11-29","current":-2.109995,"twenty":-3.85035,"median":-3.444923,"eighty":-3.067334,"marketCap":503811848},{"date":"2024-12-06","current":-2.050751,"twenty":-3.847574,"median":-3.439167,"eighty":-2.978693,"marketCap":489665943},{"date":"2024-12-13","current":-1.911755,"twenty":-3.823752,"median":-3.419021,"eighty":-2.94646,"marketCap":456477473},{"date":"2024-12-20","current":-2.009736,"twenty":-3.802749,"median":-3.405847,"eighty":-2.329653,"marketCap":479872624},{"date":"2024-12-27","current":-1.836561,"twenty":-3.764391,"median":-3.395997,"eighty":-2.153744,"marketCap":438523055},{"date":"2025-01-03","current":-1.925427,"twenty":-3.741353,"median":-3.367218,"eighty":-2.142807,"marketCap":459741913},{"date":"2025-01-10","current":-1.595028,"twenty":-3.741353,"median":-3.312536,"eighty":-2.023407,"marketCap":380851289},{"date":"2025-01-17","current":-1.745417,"twenty":-3.740777,"median":-3.298147,"eighty":-1.989684,"marketCap":416760124},{"date":"2025-01-24","current":-1.522113,"twenty":-3.738475,"median":-3.27944,"eighty":-1.964163,"marketCap":363440944},{"date":"2025-01-31","current":-1.704402,"twenty":-3.735597,"median":-3.263611,"eighty":-1.93682,"marketCap":406966805},{"date":"2025-02-07","current":-1.291973,"twenty":-3.709695,"median":-3.247782,"eighty":-1.911755,"marketCap":308489544},{"date":"2025-02-14","current":-1.187157,"twenty":-3.703939,"median":-3.22332,"eighty":-1.873019,"marketCap":283462173},{"date":"2025-02-21","current":-1.178042,"twenty":-3.690125,"median":-3.211808,"eighty":-1.829725,"marketCap":281285880},{"date":"2025-02-28","current":-1.059555,"twenty":-3.68437,"median":-3.162882,"eighty":-1.759544,"marketCap":252994070},{"date":"2025-03-07","current":-1.111963,"twenty":-3.676887,"median":-3.070787,"eighty":-1.711693,"marketCap":265507755},{"date":"2025-03-14","current":-1.041326,"twenty":-3.672858,"median":-3.006033,"eighty":-1.678881,"marketCap":248641484},{"date":"2025-03-21","current":-0.693421,"twenty":-3.667968,"median":-2.978693,"eighty":-1.565406,"marketCap":204027476},{"date":"2025-03-28","current":-1.042906,"twenty":-3.659692,"median":-2.965742,"eighty":-1.505251,"marketCap":306857324},{"date":"2025-04-04","current":-1.85837,"twenty":-3.65559,"median":-2.803137,"eighty":-1.500694,"marketCap":546793636},{"date":"2025-04-11","current":-1.198232,"twenty":-3.63199,"median":-2.286587,"eighty":-1.463027,"marketCap":352559478},{"date":"2025-04-17","current":-0.924562,"twenty":-3.622781,"median":-2.176074,"eighty":-1.280365,"marketCap":272036635},{"date":"2025-04-25","current":-0.791425,"twenty":-3.613572,"median":-2.146452,"eighty":-1.183511,"marketCap":232863359},{"date":"2025-05-02","current":-0.848748,"twenty":-3.60871,"median":-2.125945,"eighty":-1.162092,"marketCap":249729630},{"date":"2025-05-09","current":-0.930109,"twenty":-3.590112,"median":-2.016571,"eighty":-1.140673,"marketCap":273668854},{"date":"2025-05-16","current":-0.890525,"twenty":-3.561975,"median":-1.997203,"eighty":-1.105127,"marketCap":305759157},{"date":"2025-05-23","current":-0.766929,"twenty":-3.530406,"median":-1.968721,"eighty":-1.070948,"marketCap":263322832},{"date":"2025-05-30","current":-0.619565,"twenty":-3.51429,"median":-1.964163,"eighty":-1.045883,"marketCap":212725677},{"date":"2025-06-06","current":-0.530829,"twenty":-3.506511,"median":-1.95277,"eighty":-1.037224,"marketCap":182258572},{"date":"2025-06-13","current":-0.503891,"twenty":-3.48667,"median":-1.925427,"eighty":-0.984896,"marketCap":173009629},{"date":"2025-06-20","current":-0.476954,"twenty":-3.466829,"median":-1.916313,"eighty":-0.943233,"marketCap":163760687},{"date":"2025-06-27","current":-0.522906,"twenty":-3.464493,"median":-1.909477,"eighty":-0.920124,"marketCap":179538295},{"date":"2025-07-03","current":-0.538752,"twenty":-3.462191,"median":-1.878715,"eighty":-0.88573,"marketCap":184978849},{"date":"2025-07-11","current":-0.564105,"twenty":-3.459313,"median":-1.85837,"eighty":-0.848748,"marketCap":193683736},{"date":"2025-07-18","current":-0.556182,"twenty":-3.450679,"median":-1.833144,"eighty":-0.808067,"marketCap":190963459},{"date":"2025-07-25","current":-0.611642,"twenty":-3.444923,"median":-1.819538,"eighty":-0.791425,"marketCap":210005399},{"date":"2025-07-31","current":-0.649671,"twenty":-3.444923,"median":-1.775039,"eighty":-0.766929,"marketCap":223062730}],"updateTime":1754099210935}}}